A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies

Recruiting

Phase 1

A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal MalignanciesA Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies

Sponsor:

Arcus Biosciences, Inc.

Code:

NCT04104672

Conditions

Advanced Pancreatic Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AB680

Zimberelimab

Nab-paclitaxel

Gemcitabine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information